STOCK TITAN

Gilead Sciences to Release Fourth Quarter and Full Year 2020 Financial Results on Thursday, February 4, 2021

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Gilead Sciences, Inc. (Nasdaq: GILD) is set to announce its fourth quarter and full year 2020 financial results on February 4, following market close. A conference call with management will occur at 4:30 p.m. ET to discuss the results and provide a business update. Investors can access the live webcast on the company’s Investors page. Additionally, a replay will be available approximately two hours after the call until February 6. Gilead is dedicated to developing innovative medicines for serious health challenges globally.

Positive
  • None.
Negative
  • None.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2020 financial results will be released on Thursday, February 4, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s fourth quarter and full year 2020 financial results and will provide a business update.

The live webcast of the call can be accessed at the company’s Investors page at http://investors.gilead.com. Please connect to the company’s website at least 15 minutes prior to the start of the call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 877-359-9508 (U.S.) or 224-357-2393 (international) and dial the conference ID 3316988 to access the call. Telephone replay will be available approximately two hours after the call through 8:00 p.m. Eastern Time, February 6, 2021. To access the replay, please call 855-859-2056 (U.S.) or 404-537-3406 (international) and dial the conference ID 3316988. The webcast will be archived on www.gilead.com for one year.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

FAQ

When will Gilead Sciences announce its fourth quarter 2020 results?

Gilead Sciences will announce its fourth quarter 2020 results on February 4, after the market closes.

What time is Gilead's conference call for financial results?

The conference call to discuss Gilead's financial results is scheduled for 4:30 p.m. Eastern Time on February 4.

How can I access Gilead's financial results conference call?

You can access the conference call via the live webcast on Gilead’s Investors page at http://investors.gilead.com or by calling 877-359-9508 (U.S.) and 224-357-2393 (international).

Is there a replay available for Gilead's conference call?

Yes, a telephone replay will be available approximately two hours after the call through 8:00 p.m. ET on February 6.

Where can I find Gilead's archived financial results webcast?

The webcast will be archived on www.gilead.com for one year.

Gilead Sciences Inc

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Stock Data

110.72B
1.24B
0.12%
88.41%
1.42%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States of America
FOSTER CITY